Patrick Monahan is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Monahan is rated as an Elite provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Testicular Cancer, Tinnitus, Colorectal Cancer, Colonoscopy, and Endoscopy.

Nirmish Singla is an Oncologist in Lutherville, Maryland. Dr. Singla is rated as a Distinguished provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Orchiectomy.

Dr. Mohamad Allaf is Professor of Urology and Oncology, as well as Director of the Department of Urology and the Brady Urological Institute and Urologist-in-Chief of the Johns Hopkins Hospital. Dr. Allaf is a world renowned surgeon-scientist having performed more than 2,000 robotic procedures and published over 250 peer reviewed research papers in the field's best journals. As one of the busiest robotic radical prostatectomy surgeons in the world, he aims to achieve the best outcomes for his patients. Having trained with Dr. Patrick Walsh, Dr. Allaf has used Dr. Walsh's method of radical prostatectomy as the basis for his own anatomic method to this complex operation. Dr. Allaf is also amongst the leaders in kidney cancer surgery, having served on the American Urological Association Guideline Committee for Kidney Cancer. He led a team who performed the rigorous analysis to help inform the most recent guidelines that was funded by the Agency for Healthcare Research and Quality (AHRQ). He is best known for his ability to save the kidney and remove the tumor in patients with kidney tumors. Dr. Allaf runs a research endeavor aiming to decrease the morbidity associated with the treatment of cancer, and he has mentored numerous leaders in academic urology. He is actively involved in fund raising for research and education, and believes in expanding our base of support in order to advance our important mission. Dr. Allaf is rated as a Distinguished provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Renal Oncocytoma, Prostate Cancer, Nephrectomy, and Prostatectomy.

Dr. Bass attended Duke University for college and medical school, and received residency training in internal medicine and an MPH degree from the University of Pittsburgh. He completed a fellowship in general internal medicine at Johns Hopkins, and joined the Johns Hopkins faculty in 1989. His strongest research interests are in evidence-based medicine and assessment of the effectiveness, safety, and costs of medical and surgical management strategies. He has been the Director of the Johns Hopkins Evidence-based Practice Center since 2001. His teaching activities focus on medical student education at the interface between medicine and public health. He is the Director of the medical school's course on Foundations of Public Health, and Co-Director of the medical school's Scholarly Concentration in Public Health Research. He was the Director of the General Internal Medicine Fellowship at Johns Hopkins for 15 years. He served as the Editor of the Journal of General Internal Medicine for 5 years, and was the founding Editor-in-Chief of a journal dedicated to community-based participatory research called Progress in Community Health Partnerships. He has been the CEO of the Society of General Internal Medicine since 2017. He has published more than 250 peer-reviewed articles and over 50 evidence reports. He continues to have a clinical practice as a general internist. Dr. Bass is rated as an Advanced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Testicular Cancer, Varicose Veins, Type 2 Diabetes (T2D), Leydig Cell Testicular Tumor, and Orchiectomy.

William Houck is an Oncologist in Baltimore, Maryland. Dr. Houck is rated as an Advanced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Paget Disease of the Breast, Lung Cancer, Chronic B-Cell Leukemia (CBCL), and Chronic Lymphocytic Leukemia (CLL).

Dr. Noah Hahn is a medical oncologist in the Baltimore area, caring for patients with bladder cancer. He serves as the deputy director of the Greenberg Bladder Cancer Institute at the Johns Hopkins School of Medicine. Dr. Hahn earned his M.D. from Indiana University School of Medicine. He completed his residency in internal medicine at Duke University School of Medicine and performed a fellowship in medical oncology at Indiana University School of Medicine. Dr. Hahn joined the Johns Hopkins faculty in 2014. Prior to joining Johns Hopkins, Dr. Hahn was the director of the Genitourinary Medical Oncology Program at Indiana University and chief scientific officer for the Hoosier Oncology Group, a cancer research organization that evaluates innovative and promising approaches to cancer treatment. He is currently conducting clinical trials to test new therapies for bladder cancer, including those for early stage bladder cancer. Dr. Hahn is a member of the Bladder Cancer Task Force for the National Cancer Institute’s Genitourinary Cancer Steering Committee and is chair of the Bladder Cancer Subcommittee of the Eastern Cooperative Oncology Group. Dr. Hahn is rated as an Advanced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Nephrectomy.

Kasey Morrison is an Urologist in Silver Spring, Maryland. Dr. Morrison has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Neurogenic Bladder, Bilateral Hydronephrosis, Hydronephrosis, Ureteroscopy, and Prostatectomy. Dr. Morrison is currently accepting new patients.

Mark Greene is an Oncologist in Rockville, Maryland. Dr. Greene is rated as a Distinguished provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Testicular Cancer, Ovarian Cancer, Breast Cancer, Breast Cancer in Men, and Salpingo-Oophorectomy.

I am medical oncologist dedicated to the care of patients with genitourinary malignancies. My clinical and research focus is on the management of renal cell carcinoma (RCC). I have completed Medical Oncology Higher Specialist Training with Royal College of Physicians in Ireland and subsequently completed Advanced Medical Oncology Fellowship at the Memorial Sloan Kettering Cancer Center in New York. Dr. Ged is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Familial Wilms Tumor 2, Nephrectomy, and Thrombectomy.

Dr. Herati is a urologist with fellowship training in male infertility and andrology. He has specialized training to perform complex reconstructions of the reproductive system, including vasectomy reversal with vasovasostomy and vasoepididymostomy. Additionally, he has an interest in treating patients with chronic prostatitis and pelvic pain, as well as patients experiencing low testosterone, erectile dysfunction, Peyronie’s disease and benign prostatic hyperplasia (BPH). Of note, he has the ability to perform fertility treatments on patients who have experienced spinal cord injuries using nonsurgical methods of sperm extraction. Dr. Herati believes in an individualized approach to care that addresses the whole patient. He invests significant time into building a rapport with his patients so that they feel comfortable opening up about these issues, allowing him to accurately identify and manage each patient’s needs. His research interests include decoding the genetic basis of male infertility, investigating the impact of referred pain from peripheral nerves to the bladder, and characterizing the effects of low testosterone on prostate inflammation and PSA screening. Dr. Herati sees patients at both the Johns Hopkins Hospital and The Johns Hopkins Bayview Medical Center. Videos Amin Herati, M.D.Urologist. Dr. Herati is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Enlarged Prostate (BPH), Varicocele, Hypogonadism, Nephrectomy, and Prostatectomy.

As an active participant in the medical community, Mohit Narang, M.D. has served as a primary investigator and research assistant on many trials. During Dr. Narang’s fellowship, he was honored with the invitation to attend the Masterclass in Clinical Oncology at Montecatini, Italy by the European School of Oncology. He holds professional memberships with the American Society of Clinical Oncology, American Society of Hematology, as well as the European Society of Medical Oncology. Learn more at marylandoncology.com. Dr. Narang is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Multiple Myeloma, Agranulocytosis, Paget Disease of the Breast, Thrombocytopenia, and Bone Marrow Transplant.

Arun Bhandari, M.D. is a native of Maryland and grew up in Silver Spring area. He earned his medical degree from Punjabi University and Government Medical College, Punjab, India and completed his internship and residency in Internal Medicine at New York University program in Queens, NY. He completed his Hematology and Oncology fellowship at University of Tennessee Health Science Center, Memphis, TN, Georgetown University and Washington Hospital Center, Washington, DC and NHLBI at National Institute of Health, Bethesda, MD. He served as a chief fellow at Georgetown University and Washington Hospital Center, Washington, D.C. After completing his fellowship in 2005, he joined as faculty at Allegheny General Hospital in Pittsburgh, PA, where he was actively involved in teaching fellows and residents. He joined COHA in 2007 at which time he opened a location in Annapolis and Kent Island. He has interest in head and neck cancer, brain cancer, breast cancer, lung cancer, gastrointestinal cancer(colon, pancreas, liver, gastric, esophageal etc.), genitourinary cancer (kidney, prostate, bladder etc.), gynecological cancer (ovarian, uterine, cervical, vaginal etc.), skin cancer, Lymphoma, Myeloma, Leukemia and various other blood disorders. He is a member of the American Society of Clinical Oncology and American Society of Hematology. He currently sees patients at Annapolis Cancer Center and Kent Island Center. He speaks English, Hindi, and Punjabi. Dr. Bhandari is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Pleuropulmonary Blastoma, Multiple Myeloma, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia.

Dr. Heather Noelle Di Carlo is an associate professor of urology at the Johns Hopkins University School of Medicine. She treats all pediatric urological disorders in young males and females while specializing in renal sparing surgery and complex reconstruction of the genitourinary tract in patients with the exstrophy-epispadias complex, disorders of sexual development (DSD) and other congenital anomalies. She serves as the Director of Pediatric Urology Research and is the interim Division Director of Pediatric Urology. A native of New York, Dr. Di Carlo graduated from Emory University with a B.S. in neuroscience and music, and the State University of New York at Stony Brook School of Medicine. Following general surgery and urology residency training at Stony Brook Medical Center, she completed a pediatric urology fellowship at the James Buchanan Brady Urological Institute. Dr. Di Carlo has special clinical and basic science interests in the exstrophy-epispadias complex, spina bifida and renal transplantation. Dr. Di Carlo is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. Her top areas of expertise are Exstrophy of the Bladder, Exstrophy-Epispadias Complex, Cloacal Exstrophy, Bladder Reconstruction, and Osteotomy.

Andrew Mener, M.D. has experience treating a wide range of adult hematologic and oncologic disorders, with a particular interest in treating breast, lung, gastrointestinal and hematologic malignancies. He takes great pride in delivering personalized, compassionate care and strives to effectively explain complex treatment options to his patients. He strongly believes in the importance of treating each and every patient as an individual. Learn more at marylandoncology.com. Dr. Mener is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Severe Congenital Neutropenia.

Dr. Max Kates is the R. Christian B. Evensen Professor and an associate professor of urology and oncology at the Brady Urological Institute at Johns Hopkins. He also directs the Division of Urologic Oncology for the Brady Urological Institute. Dr. Kates completed his undergraduate degree at Wesleyan University in Connecticut before pursuing his medical degree at Mount Sinai School of Medicine in New York. He then went on to train at Johns Hopkins for his urologic residency and Society of Urologic Oncology (SUO) fellowship. Dr. Kates has expertise in all areas of urologic oncology, with a particular emphasis on bladder and prostate cancer. With training in open, endoscopic, and robotic surgical approaches, Dr. Kates’ surgical philosophy is to assess the unique needs of each patient, and develop the right treatment plan for their malignancy. He is very hands on in his approach in the clinic and the operating room, and believes open communication with the patient, the patient’s family, and referring providers is key to ensuring a speedy recovery. As the clinical director of the bladder cancer multidisciplinary clinic, Dr. Kates works with the team at the Johns Hopkins Greenberg Bladder Cancer Institute to deliver a personalized approach to bladder cancer utilizing cutting edge precision medicine approaches. Dr. Kates’ research interests involve novel treatments for cancers of the urinary tract. Dr. Kates has authored more than 135 journal articles in the fields of bladder, prostate, and kidney cancer. He currently has a provisional patent for a novel intravesical chemotherapy developed with nano-engineer collaborators. Additionally, Dr. Kates has made important discoveries into the mechanism of action of intravesical BCG, the most common treatment for bladder cancer. He is the principal investigator on multiple trials, and is currently leading EA8212 BRIDGE, which is a randomized trial open in over 150 centers in the United States comparing BCG to GemDoce chemotherapy for early stage bladder cancer. To inquire about an appointment or make a referral, Dr. Kates can be contacted by phone (410) 614-0009. Dr. Kates is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy.

Dr. Jean Hoffman-Censits is a genitourinary cancer specialist in Baltimore, caring for patients with urothelial cancers of the bladder and upper tract. She serves as co-leader of the Women’s Bladder Cancer Program in the Greenberg Bladder Cancer Institute at the Johns Hopkins University School of Medicine. Dr. Hoffman-Censits received her undergraduate degree in neuroscience from Trinity College. She earned her M.D. degree from the Sidney Kimmel Medical College of Thomas Jefferson University. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in hematology and oncology at Temple University Medical Center. She joined the Johns Hopkins faculty in 2018. Dr. Hoffman-Censits's research interests focus on urothelial cancers. Her clinical research has helped identify urothelial cancer sub-types and establish new treatments for bladder and upper tract urothelial cancers. She is a member of the American Medical Association, the American Society of Clinical Oncology, the American Urological Association and the Society for Immunotherapy of Cancer. Dr. Hoffman is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. Her top areas of expertise are Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Bladder Reconstruction.

Karan Rao is an Interventional Radiologist in Baltimore, Maryland. Dr. Rao is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Testicular Torsion, Stroke, Osteoarthritis, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Mark Ball is a Plastic Surgeon and an Urologist in Bethesda, Maryland. Dr. Ball is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Von Hippel-Lindau (VHL) Syndrome, Renal Cell Carcinoma (RCC), Renal Oncocytoma, Nephrectomy, and Prostatectomy.

Vladimir Kakitelashvili is an Urologist in Centreville, Maryland. Dr. Kakitelashvili is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Orchitis, Familial Prostate Cancer, Prostate Cancer, Ureteroscopy, and Prostatectomy.

Dr. Elias is a medical oncologist and physician scientist specializing in the treatment of genitourinary (kidney, prostate, bladder) cancers. Dr. Elias received his medical degree from the University of Miami Medical School. He completed his residency in Internal Medicine at the University of Texas Southwestern in Dallas, TX. He went on to complete a fellowship in Medical Oncology at Johns Hopkins in Baltimore MD. Dr. Elias’ laboratory is focused on the development of biomarkers and novel therapeutics for genitourinary malignancies. Dr. Elias is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Testicular Yolk Sac Tumor, Testicular Cancer, Acute Promyelocytic Leukemia, and Nephrectomy.